Complex Litigation Blog - Recent Legal News

View updates for:
Published: April 25th, 2017
Pennsylvania’s seventh Risperdal gynecomastia trial came to a premature end last week, after the judge hearing the case granted the defense a Motion for Nonsuit. Attorneys representing the plaintiff have promised to appeal the decision. 5,000+ Risperdal Lawsuits Pending in Pennsylvania The case ...Read More
Published: April 12th, 2017
The U.S. Judicial Panel on Multidistrict Litigation (JPML) has agreed to create a centralized proceeding for all federally-filed lawsuits involving certain brain injuries allegedly associated with use of the Mirena IUD.  A Transfer Order dated April 6th indicates that these claims will now undergo ...Read More
Published: March 30th, 2017
Plaintiffs who have filed Stryker hip lawsuits in state and federal courts following the recall of certain LFIT Anatomic CoCr V40 Femoral Heads are seeking to have their cases centralized in mass tort proceedings. Decision on the various petitions and motions could come some time in the next month. ...Read More
Published: March 21st, 2017
Wright Medical Technology has been denied its bid to overturn the verdict in the first federal trial involving its metal-on-metal Conserve hip replacement. In a decision handed down on Monday, the 11th Circuit Court of Appeals upheld the $2.1 million judgment awarded to a former ski instructor who s...Read More
Published: March 7th, 2017
Plaintiffs who have requested the centralization of all federally-filed Mirena IUD lawsuits involving a serious brain injury called pseudotumor cerebri (aka idiopathic intracanial hypertension) will have a chance to make their case later this month.  According to an Order dated February 14th, the U...Read More
Published: March 2nd, 2017
Johnson & Johnson and DePuy Orthopaedics continue to face new product liability lawsuits over a metal-on-metal version of the Pinnacle Acetabular Cup Hip Replacement System. In a recent filing with the U.S. Securities and Exchange Commission, Johnson & Johnson acknowledged that at least 9,40...Read More
Published: February 21st, 2017
Onlyza, a medication that was recently the subject of heart failure warnings, doesn’t appear to be delivering for  AstraZeneca PLC.  According to the company’s latest earnings report, sales of the Type 2 diabetes medication were down a staggering 22% during the final quarter of 2016. Onglyz...Read More
Published: February 9th, 2017
Zofran lawsuit defendant, GlaxoSmithKline, is trying to convince a federal judge to dismiss fraud claims in hundreds of cases involving the drug’s alleged association with serious birth defects. However, plaintiffs reject assertions that their master pleading  lacks adequate  details regarding ...Read More
Published: February 3rd, 2017
Canadian regulators have issued a new safety warning for Levaquin and other fluoroquinolone antibiotics, after a review identified dozens of serious complications possibly related to their use. The prescribing information for all fluoroquinolones marketed in Canada is now being revised to include in...Read More
Published: January 18th, 2017
The federal court overseeing pretrial proceedings for hundreds of peripheral neuropathy lawsuits filed against the manufacturers of Levaquin and other fluoroquinolone antibiotics convened it most recent Status Conference in December. Minutes posted on the Court’s website indicate that discussions ...Read More
The National Trial Lawyers